Heartburn: Clinical Trials

34 trials for Heartburn, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 6 unknown, 2 recruiting, 2 terminated. 34 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable34Completed 21, Unknown 6, Recruiting 2, Terminated 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1

Follow Heartburn: new trials by email Literature Review of Heartburn trials Research Report on Heartburn

Trials (filtered) newest first · largest first

All 34 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antireflux Surgery Without Preoperative Esophageal Manometry
Preoperative workup without high-resolution esophageal manometry, Standard preoperative workup with high-resolution esophageal manometry - GERD, Hiatal Hernia
Not applicableNot yet recruitingMcMaster University962026-10-012026-08-10
New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)
Esophageal barrier medical device, Placebo oral formulation - GERD (Gastroesophageal Reflux Disease), NERD
Not applicableRecruitingCellmedis502026-05-282026-07-10
Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms
PCAB-test guided - GERD, Acid Reflux, Treatment
Not applicableEnrolling by invitationMahidol University1202026-03-182026-07-16
A Clinical Trial of PepZinGIĀ® for Acute Heartburn Relief and Sleep Outcomes
PepZinGI, Placebo - Heartburn
Not applicableCompletedNutriScience Innovations, LLC502026-01-152026-06-17
The Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension on Outpatients With Gastroesophageal Reflux Disease
Anvitra Gastric Suspension - GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency, GERD (Heartburn, Regurgitation, and Dyspepsia) Severity
Not applicableCompletedHaiphong University of Medicine and Pharmacy272024-08-062025-09-15
A Pre-market, Two-stages Interventional Clinical Investigation to Evaluate the Safety and the Performance of Fibroin Syrup in Reducing the Gastroesophageal Reflux Disease (GERD) Symptomatology in Nonerosive Reflux Disease (NERD) Patients
Syrup made by hyaluronic acid - GERD (Heartburn, Regurgitation, and Dyspepsia), Gastroesophageal Reflux (GERD)
Not applicableCompletedRose Pharma SA472024-07-242026-05-04
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers
Antareit - Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract
Not applicableUnknownValenta Pharm JSC502024-04-252024-07-22
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
Breath Testing - Gastroesophageal Reflux, Regurgitation
Not applicableRecruitingMayo Clinic502023-11-172026-02-12
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms
Butyrate Formulation, Butyrate + Polyphenol Formulation, Placebo - Gut Health
Not applicableCompletedSupplement Formulators, Inc.1432023-10-312026-01-13
The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms.
LEFT smartwatch app - Gastroesophageal Reflux, Heartburn
Not applicableCompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)182023-10-012025-05-31
Smartphone App-assisted PPI
App-based treatment support - Heartburn, Dyspepsia
Not applicableCompletedUniversity Hospital, Basel, Switzerland602023-09-052025-02-13
Study to Evaluate the Efficacy of Poppi Apple Cider Vinegar Prebiotic Soda to Improve Gut Health In Participants
Drink Poppi Soda - IBS - Irritable Bowel Syndrome
Not applicableCompletedDrink Poppi382022-04-012022-06-15
Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With Heartburn
Panosyl-isomaltooligosaccharides (PIMO) 1g (1.4 ml), Placebo 1.4 ml - Heartburn
Not applicableCompletedMicrobiome Health Sciences2112022-02-102023-07-18
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers
Magaldrate - Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract
Not applicableCompletedValenta Pharm JSC402021-07-072024-08-14
Implementation of a Minor Ailment Service in Community Pharmacy Practice
Minor ailment service - Acne, Bites
Not applicableCompletedUniversidad de Granada209872020-10-012023-12-07
Remote Guided Caffeine Reduction
Caffeine Reduction Manual - Caffeine Dependence, Anxiety
Not applicableCompletedJohns Hopkins University1092020-09-102025-01-14
Efficacy of Vitamin C Supplement vs Spinal Manipulation to Treatment in Lateral Epicondylitis
Vitamin C, spinal manipulation, Transcutaneous electrical nerve stimulation (TENS) - Lateral Epicondylitis, Tennis Elbow
Not applicableUnknownUniversidad Rey Juan Carlos1302020-05-212020-06-26
Study of Dietary Patterns and Food Diversity in Russian GERD Patients
Dietary assessment - Gastroesophageal; Reflux With Esophagitis, Gastroesophageal Reflux
Not applicableUnknownRussian Academy of Medical Sciences1502020-01-302022-02-03
Upset Stomach Relief for Mild and Moderate Indigestion and Heartburn
HLNatural, Inc. Upset Stomach Relief - Indigestion, Heartburn
Not applicableCompletedHawthorne Effect Inc.1612019-10-162021-11-15
Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients
Diaphragm Training - GERD
Not applicableCompletedMayo Clinic1922019-09-242023-01-19

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Gastroesophageal Reflux (22)  ·  Dyspepsia (8)  ·  Diarrhea (3)  ·  Abdominal Pain (2)  ·  Constipation (2)  ·  Cough (2)  ·  Duodenal Ulcer (2)  ·  Esophagitis (2)  ·  Esophagitis, Peptic (2)  ·  Non-Erosive Reflux Disease (2)  ·  Sleep Wake Disorders (2)  ·  Acne Vulgaris (1)  ·  Anxiety Disorders (1)  ·  Barrett Esophagus (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (34)  ·  Signs and Symptoms (34)  ·  Signs and Symptoms, Digestive (34)  ·  Digestive System Diseases (26)  ·  Gastrointestinal Diseases (26)  ·  Deglutition Disorders (22)  ·  Esophageal Diseases (22)  ·  Esophageal Motility Disorders (22)  ·  Intestinal Diseases (6)  ·  Neurologic Manifestations (6)  ·  Duodenal Diseases (4)  ·  Pain (4)  ·  Peptic Ulcer (4)  ·  Stomach Diseases (4)  ·  Gastroenteritis (3)

Interventions

Ascorbic Acid (1)  ·  Biofeedback, Psychology (1)  ·  Butyrates (1)  ·  Dexlansoprazole (1)  ·  Diet, Fat-Restricted (1)  ·  Dietary Supplements (1)  ·  Lansoprazole (1)  ·  Manipulation, Spinal (1)  ·  Musculoskeletal Manipulations (1)  ·  Nutrition Assessment (1)  ·  Transcutaneous Electric Nerve Stimulation (1)  ·  magaldrate (1)

Sponsors

Mayo Clinic (3)  ·  EndoGastric Solutions (2)  ·  Valenta Pharm JSC (2)  ·  Aboca Spa Societa' Agricola (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Azienda Ospedaliera Universitaria Policlinico "G. Martino" (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Cellmedis (1)  ·  Changhai Hospital (1)  ·  Cook Group Incorporated (1)  ·  Dallas VA Medical Center (1)  ·  Drink Poppi (1)  ·  Haiphong University of Medicine and Pharmacy (1)  ·  Hawthorne Effect Inc. (1)

Countries

United States (18)  ·  Russia (3)  ·  Spain (3)  ·  Italy (2)  ·  Canada (1)  ·  China (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  Vietnam (1)

Top investigators

Andree Koop, MD (1)  ·  Andrew Swick, Ph.D (1)  ·  Christopher J Yelvington, DPT (1)  ·  David I. Rosenthal, MD, MA, BA (1)  ·  Dustin Lee, PhD (1)  ·  Gioacchino Calapai, MD (1)  ·  Glen A. Lehman, MD (1)  ·  Isabelle Arnet, Dr. PD (1)  ·  Karim Trad, MD, FACS (1)  ·  Michael Shapiro, MD (1)  ·  Michelle Dossett, MD, PhD, MPH (1)

Results publications

PMID 15365964, PMID 19028251, PMID 22923162, PMID 24378321, PMID 25246239, PMID 25284142, PMID 26149189, PMID 26422466, PMID 27187303, PMID 27694141, PMID 28861199, PMID 30081223

NIH funding

R01DA003890 (1), R01DK063621 (1)